Denali Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Denali Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Denali Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $23.7M, a 11.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $23.7M -$3.03M -11.3% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $24.5M -$2.88M -10.5% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $25.3M -$2.74M -9.77% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $26M -$4.39M -14.4% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $26.8M -$4.52M -14.5% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $27.4M -$2.34M -7.86% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $28M -$2.21M -7.32% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $30.4M -$306K -1% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $31.3M +$75K +0.24% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $29.8M -$1.87M -5.9% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $30.3M -$1.97M -6.12% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $30.7M -$1.88M -5.75% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $31.2M -$1.78M -5.4% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $31.6M -$1.69M -5.07% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $32.2M -$1.39M -4.13% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $32.6M -$1.31M -3.85% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $33M -$1.37M -3.98% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $33.3M -$1.34M -3.85% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $33.6M -$781K -2.27% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $33.9M Dec 31, 2019 10-K 2021-02-26
Q3 2019 $34.3M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $34.6M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $34.4M Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.